12-10938754-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_023922.2(TAS2R14):āc.454A>Cā(p.Ile152Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000263 in 152,162 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_023922.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAS2R14 | NM_023922.2 | c.454A>C | p.Ile152Leu | missense_variant | 1/1 | ENST00000537503.2 | NP_076411.1 | |
PRH1-TAS2R14 | NM_001316893.2 | c.208-177A>C | intron_variant | NP_001303822.1 | ||||
PRH1-PRR4 | NR_037918.2 | n.544+34901A>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAS2R14 | ENST00000537503.2 | c.454A>C | p.Ile152Leu | missense_variant | 1/1 | NM_023922.2 | ENSP00000441949 | P1 | ||
ENST00000703543.1 | c.-59+34901A>C | intron_variant | ENSP00000515364 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 152162Hom.: 0 Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome AF: 0.0000263 AC: 4AN: 152162Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74342
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jul 19, 2023 | The c.454A>C (p.I152L) alteration is located in exon 1 (coding exon 1) of the TAS2R14 gene. This alteration results from a A to C substitution at nucleotide position 454, causing the isoleucine (I) at amino acid position 152 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at